.jpg)
Oops! Something went wrong while submitting the form.
Services
Saline given by drip or under the skin can change the orthostatic picture more sharply than the same volume of fluid given by mouth. For some people in the dysautonomia pathway, that change is useful — during a flare, during recovery from a viral episode, or when standing has become harder than the rest of the plan was built for.
The fluid is not a cure for POTS. It is a tool that does two things at once. It can support symptoms while the rest of the plan does its slower work. And it can give the clinical team useful diagnostic information: a strong response usually points toward hypovolemic mechanisms, while a limited response may point toward neuropathic or hyperadrenergic patterns. The same intervention reads differently in different sub-patterns, and that reading is part of what the work is for.
Most courses run for a defined period — typically a few months — and then either step down, transition to a subcutaneous route, or stop altogether as other treatments take effect. The aim from the first session is to not need the next one in the longer run.
This service is for people already in the dysautonomia pathway who need short-term fluid support for symptoms that are not being held by oral hydration alone — particularly during flares, after viral illness, in hot weather, or while a longer treatment plan is being set up. It is not an emergency service and it is not a replacement for medical management of the underlying condition.
A nurse practitioner reviews the current dysautonomia picture, looks for the signs that fluid therapy is likely to help, checks current medications and treatments, and confirms safety. Where IV fluids are not the right tool, that is said.
A fluid-therapy prescription is built around the specific presentation — composition, frequency, expected duration, and the parameters that will be tracked between sessions. A typical starting course is weekly or fortnightly for an initial defined period; the prescription is not open-ended.
The first session is conducted in clinic with monitoring of vital signs, symptom response, and any adverse reactions. The first session also serves as a baseline: how strongly and how durably the person responds is recorded, because that response is part of the diagnostic reading.
Sessions continue at the prescribed cadence. The response pattern — how long the benefit lasts, what brings it back, what changes between sessions — is documented in the same record the rest of the biio. care team can see. If the benefit is not holding, the prescription changes; the course is not run on autopilot.
A strong, durable response usually points toward a hypovolemic mechanism. A weak or short-lived response may point toward neuropathic or hyperadrenergic patterns, or toward another condition contributing to symptoms. That reading is fed back into the rest of the dysautonomia pathway and changes what the next steps look like.
The aim is to step down, not to continue indefinitely. Where the response is sustained, a subcutaneous route may be considered for lower-burden ongoing support. Where the other treatments in the plan have started to do their work, the IV course can stop.
When fluid therapy is helping, the change is felt at the level of the day. Standing for longer than a few minutes becomes possible. Cognition holds for longer before it thins. Recovery from a small task takes hours rather than days. For people whose flares were costing them whole weeks, the difference is often the difference between participating and not.
The clinical picture also becomes clearer over the course. The response — how strong, how lasting, whether it scales with frequency — gives the rest of the team a piece of diagnostic information that no single test provides on its own.
This work is meant to be temporary scaffolding. The reading it provides, and the symptom relief it gives during a difficult window, is what justifies it. The aim is for the rest of the plan to take over.